Liver Metastases Articles & Analysis: Older
5 news found
For patients with cancer in the liver and severely impaired kidney function respondents currently prefer not to use a contrast agent when performing an MRI (unenhanced), even though this reduces the ability to detect and visualize cancer lesions. ...
Orviglance is Ascelia Pharma’s oral investigational MRI imaging agent used in the visualization of cancer in the liver and is currently in Phase 3 development. The Hepatic Impairment Study evaluates if patients with different degrees of hepatic impairment can tolerate Orviglance since Orviglance is selectively taken up and excreted by the liver. The study ...
As communicated earlier, the results showed that a higher number of liver lesions was detected by the three independent readers for Orviglance compared to the liver-specific gadolinium contrast agent. ...
The presentation today at RSNA shows specifically the results of the efficacy parameters in the study including: Number of lesions detected Size of the detected lesions Lesion border delineation Lesion contrast compared to liver The results showed that a higher number of liver lesions was detected by all three independent readers for Orviglance compared ...
Introduction Anliprogestins have demonstrated promising activity against breast and gynecological cancers, but liver-related safety concerns limited the advancement of this therapeutic class. ...